By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year. These medications are "slated to make a big clinical ...

Patients will be tested for amyloid before starting the medication ... measures memory, thinking and daily functioning. Kisunla becomes the third amyloid-clearing Alzheimer's drug approved ...

The U.S. Food and Drug Administration approved a new schizophrenia treatment on Thursday for the first time in decades, ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...